Form 4 for KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.
Accepted 2026-09-10 20:25:49 ET · period of report 2026-09-08 · accession 0001193125-26-388297 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 20:25 | 2026-09-08 | KMTS | Ladone Mary Kay | Dir | S - Sale | $25.20 | -3,908 | 37.5K | -9% | -$98.5K | |
| 2026-09-10 20:25 | 2026-09-09 | KMTS | Ladone Mary Kay | Dir | A - Grant | — | +7,217 | 44.7K | +19% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-09-08 | S | D | 3,908 | $25.20 | 37,507 | D | — | — | (F1) The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. (F2) The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9100 to $25.4300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. (F3) Includes 17,512 Common Shares received from West Affum Holdings, L.P., in a pro rata distribution exempt pursuant to Rule 16a-9. |
| 2 | Common | Common Shares | 2026-09-09 | A | A | 7,217 | — | 44,724 | D | — | — | (F4) The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date. (F4) The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date. |